
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PAK5 CRISPR/Cas9 KO Plasmid (h) | sc-404073 | 20 µg | $397.00 |
PAK5 (p21-activated kinase 5) is a serine/threonine kinase activated downstream of Rho-family GTPases such as Cdc42 and Rac, integrating signals that regulate cytoskeletal remodeling, neurite outgrowth, and cell survival. It localizes to mitochondria and other subcellular compartments where it can influence apoptosis-related signaling and stress responses. PAK5 participates in pathways governing cell motility and polarity through phosphorylation of cytoskeletal and signaling intermediates, linking extracellular cues to changes in adhesion and migration. Dysregulated PAK5 activity or expression has been associated with aberrant proliferation, invasion, and therapy resistance phenotypes in multiple cancer contexts and is also relevant to neurobiology due to its roles in neuronal development and synaptic function.
PAK5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PAK5 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PAK5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PAK5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PAK5 protein expression.
This CRISPR knockout system enables efficient generation of PAK5-deficient cell models for investigation of PAK5 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.